Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell‐Derived Extracellular Vesicles
Yuluo Rong,
No information about this author
Jiaxing Wang,
No information about this author
Tao Hu
No information about this author
et al.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(31)
Published: June 19, 2024
Abstract
Spinal
cord
injury
(SCI)
is
a
severe
neurological
condition
that
frequently
leads
to
significant
sensory,
motor,
and
autonomic
dysfunction.
This
study
sought
delineate
the
potential
mechanistic
underpinnings
of
extracellular
vesicles
(EVs)
derived
from
ginsenoside
Rg1‐pretreated
neuronal
cells
(Rg1‐EVs)
in
ameliorating
SCI.
These
results
demonstrated
treatment
with
Rg1‐EVs
substantially
improved
motor
function
spinal
cord‐injured
mice.
enhance
microglial
polarization
toward
M2
phenotype
repressed
oxidative
stress,
thereby
altering
immune
responses
decreasing
inflammatory
cytokine
secretion.
Moreover,
diminish
reactive
oxygen
species
accumulation
enhanced
neural
tissue
repair
by
regulating
mitochondrial
function.
Proteomic
profiling
highlighted
enrichment
MYCBP2
Rg1‐EVs,
functional
assays
confirmed
knockdown
counteracted
beneficial
effects
vitro
vivo.
Mechanistically,
implicated
ubiquitination
degradation
S100A9,
promoting
M2‐phenotype
reducing
stress.
Overall,
these
findings
substantiated
pivotal
role
protection
recovery
following
SCI
through
MYCBP2‐mediated
S100A9.
research
offers
novel
insights
into
therapeutic
strategies
against
supports
clinical
Rg1‐EVs.
Language: Английский
Recent advances in delivery systems of ginsenosides for oral diseases
Yuqing Gu,
No information about this author
Ze Li,
No information about this author
Shu Zhou
No information about this author
et al.
Phytomedicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 156422 - 156422
Published: Jan. 1, 2025
Language: Английский
Neurological Emergency Treatment Strategy: A Neuron-Targeted Regulation System for Reactive Oxygen Species Metabolism through Ferroptosis Modulation
Yibo Ying,
No information about this author
Xiong Cai,
No information about this author
Peng Dai
No information about this author
et al.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 25, 2025
Spinal
cord
injury
(SCI)
represents
a
significant
clinical
challenge.
Following
SCI,
the
implementation
of
protective
measures
for
neurons
is
critically
important.
Current
applications
hormone
pulse
therapy
exhibit
variable
efficacy
and
considerable
side
effects,
highlighting
an
urgent
need
therapeutic
strategies.
This
study
investigates
pathological
conditions
ischemia
hypoxia
in
SCI
region,
complemented
by
early
transcriptome
sequencing
postinjury.
Our
findings
suggest
that
targeting
ferroptosis
pivotal
neuroprotection
following
SCI.
Aiming
at
cascade
effect
mitochondrial
damage
leading
to
reactive
oxygen
species
(ROS)
production,
along
with
extensive
ROS-mediated
lysosomal
during
signaling,
we
developed
liposome-based
system
regulating
iron
metabolism─DTLS@CAT.
innovative
liposome
designed
specifically
target
neuronal
mitochondria,
effectively
eliminate
mitoROS,
modulate
complex
interactions
among
metabolism,
lysosomes,
ROS
facilitate
recovery
from
Language: Английский
Systematic Review and Network Meta‐Analysis of the Effects of Plant Extracts on Cognitive Function and Quality of Life in Stroke Patients
Ji Li,
No information about this author
Jingfen Jin,
No information about this author
Yifeng Cheng
No information about this author
et al.
Phytotherapy Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 13, 2025
ABSTRACT
In
recent
years,
numerous
researchers
have
focused
on
plant
extracts
derived
from
traditional
medicines
to
treat
stroke,
as
these
may
improve
patients'
cognitive
function
and
quality
of
life.
This
study
aims
evaluate
the
effects
nine
distinct
(
Ginkgo
biloba
extract,
Ginsenosides,
Berberine,
St.
John's
Wort
Resveratrol,
Gastrodin,
Crocus
sativus
L.,
Moringa
oleifera
Seed
Panax
Notoginseng
Saponins)
life
in
stroke
patients.
seeks
conduct
a
network
meta‐analysis
assess
impact
Researchers
systematically
searched
Embase,
PubMed,
Cochrane
Library,
Web
Science
databases
database
inception
through
October
2024
for
randomized
controlled
trials
(RCTs)
exclusively(no
language
restrictions).
The
selected
studies
were
evaluated
methodological
via
bias
risk
assessment
tool,
data
analysis
software
was
used
analyze
accordingly.
primary
outcome
measures
included
following
scales:
National
Institute
Health
Stroke
Scale
(NIHSS),
Modified
Rankin
(mRS),
Activities
Daily
Living
(ADLs),
Barthel
Index
(BI),
Montreal
Cognitive
Assessment
(MOCA),
Mini‐Mental
State
Examination
(MMSE).
Treatment
ranked
based
probability
values
surface
under
cumulative
ranking
curve
(SUCRA).
Moreover,
cluster
applied
six
scales
that
reflect
After
screening,
48
eligible
included,
covering
6599
patients
evaluating
different
extract
treatments.
Specifically,
results
33
NIHSS
score,
10
mRS
11
ADL
BI
MMSE
eight
MOCA
score.
Findings
indicate
(SUCRA
71.2%)
most
effective
reducing
scores,
Berberine
84.1%)
99.1%)
showed
highest
efficacy
enhancing
scores.
Ginsenosides
improving
74.7%),
93%),
79.7%)
NMA
indicates
that,
compared
placebo,
can
enhance
provides
valuable
insights
into
using
treatment,
potentially
guiding
clinical
practice,
but
there
are
some
unavoidable
limitations
our
study,
including
heterogeneity,
differences
extraction
methods
extracts,
lack
consideration
social
support
systems
dose
effects.
Future
longer
follow‐up,
larger
samples,
more
methodologically
rigorous
recommended
clearly
establish
dosages
Language: Английский
Effect of microglial Pd1 on glial scar formation after spinal cord injury in mice
Yunyun Cai,
No information about this author
Zhihao Lin,
No information about this author
Xin Shen
No information about this author
et al.
Journal of Biological Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108489 - 108489
Published: April 1, 2025
The
crosstalk
between
microglia
and
astrocytes
following
spinal
cord
injury
(SCI)
greatly
decides
the
prognosis.
However,
a
comprehensive
understanding
of
molecular
mechanisms
by
which
regulate
astrocytic
activity
post-SCI
is
lacking.
Programmed
cell
death
protein
1
(Pdcd1,
Pd1)
plays
crucial
role
in
modulating
immune
responses
exerting
suppressive
effects
on
peripheral
cells
within
central
nervous
system
(CNS).
Previous
studies
have
shown
involvement
Pd1
pathogenesis
SCI;
however,
microglial
activation
glial
scar
formation
remains
elusive.
Here,
we
demonstrated
that
pharmacological
depletion
using
minocycline
decreased
expression
TNF-α
IL-6
while
concurrently
increasing
IL-10
SCI,
thereby
facilitating
motor
function
recovery
mice.
We
observed
an
increase
injured
after
with
precise
localization
microglia.
Based
knockout
(KO)
mice,
further
revealed
deficiency
disrupted
formation,
leading
to
increased
inflammation,
impeded
nerve
regeneration,
enlarged
tissue
damage,
compromised
functional
SCI.
In
vitro
study
showed
siRNA-mediated
inhibition
followed
lipopolysaccharide
(LPS)
treatment
significantly
inhibited
astrocyte
migration
upregulated
secretion
CXCL9
from
microglia,
indicating
regulates
through
inflammatory
microenvironment.
Our
gains
new
mechanistic
insight
into
how
fate
SCI
promotes
as
promising
therapeutic
target
for
Language: Английский